- fever since 2 weeks before admitted - pallor,fever
- bone pain since 3 weeks before admitted -multiple lymphnode enlargement High Risk B-cell ALL with CNS Leukemia - pale since 1 month before admitted - hepatosplenomegaly
Currative: ALL high risk chemotherapy Supportive :
Management protocol 2016 with modified for CNS Transfusion Leukemia Nutrition according to RDA
Problem Early response Ad Vitam : dubia ad malam
Lab evaluation Ad Functionam : dubia ad malam Education Complication Ad Sanationam : dubia ad malam Monitoring Plan
Pediatr Blood Cancer. 2016. Level of Evidence 1b, recommendation A
Prognosis J Clin Oncol. 2017. Level of Evidence 2b, recommendation B. Pediatr Blood Cancer. 2017. Level of Evidence 2b, recommendation A Middle East Journal of Cancer. 2016. Level of Evidence 2b, recommendation B